Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Cash from Operations (Quarterly): -0.126M for June 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.126M |
| March 31, 2023 | -33.51M |
| December 31, 2022 | 37.56M |
| September 30, 2022 | -13.24M |
| June 30, 2022 | 42.99M |
| March 31, 2022 | -16.61M |
| December 31, 2021 | 8.081M |
| September 30, 2021 | 1.067M |
| June 30, 2021 | 8.593M |
| March 31, 2021 | 10.48M |
| December 31, 2020 | 19.76M |
| September 30, 2020 | 5.627M |
| June 30, 2020 | 20.95M |
| March 31, 2020 | 3.158M |
| December 31, 2019 | -3.201M |
| September 30, 2019 | 10.61M |
| June 30, 2019 | 22.39M |
| March 31, 2019 | 26.18M |
| December 31, 2018 | 38.11M |
| September 30, 2018 | 3.688M |
| June 30, 2018 | 5.667M |
| March 31, 2018 | 4.921M |
| Date | Value |
|---|---|
| December 31, 2017 | 25.92M |
| September 30, 2017 | 7.886M |
| June 30, 2017 | 37.55M |
| March 31, 2017 | -12.44M |
| December 31, 2016 | 39.56M |
| September 30, 2016 | 13.17M |
| June 30, 2016 | -2.624M |
| March 31, 2016 | 3.108M |
| December 31, 2015 | -16.80M |
| September 30, 2015 | -6.635M |
| June 30, 2015 | -12.12M |
| March 31, 2015 | 25.84M |
| December 31, 2014 | -7.875M |
| September 30, 2014 | -7.128M |
| June 30, 2014 | -4.666M |
| March 31, 2014 | -2.072M |
| December 31, 2013 | 0.023M |
| September 30, 2013 | -0.3154M |
| June 30, 2013 | -2.733M |
| March 31, 2013 | -1.022M |
| December 31, 2012 | -1.809M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-33.51M
Minimum
Mar 2023
42.99M
Maximum
Jun 2022
6.105M
Average
5.627M
Median
Sep 2020
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 3.712B |
| Verrica Pharmaceuticals Inc | -8.558M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
| iBio Inc | -3.715M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.006M |
| Cash from Financing (Quarterly) | -6.411M |